This site is intended for health professionals only

Saturday 19 October 2019

Paolo Prandoni MD PhD

Articles by this author

Fri 5 October
Fri 5 October
Fixed-dose treatment with the novel direct oral anticoagulants is likely to replace subcutaneous low-molecular-weight heparins for most cancer patients with venous thromboembolism